Skip to content
DataLookout
Menu

ROGARNCT07816640

Renal Oxygenation-Guided AKI Reduction Trial

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Start date pushed from Sep 20, 2026 to Nov 20, 2026
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Incidence of postoperative acute kidney injury
Timeframe: From the end of surgery through postoperative day 7 or hospital discharge, whichever occurs first

Secondary (10)

Severity of postoperative AKI
Postoperative peak serum creatinine
Persistence and recovery of AKI
New Initiation of Renal Replacement Therapy Within 7 Days After Surgery
Renal Replacement Therapy Dependence
Show 5 moreShow less
In-hospital clinical recovery outcomes
Postoperative morbidity and complication burden
Health-related quality of life
Healthcare resource use and direct medical costs
All-Cause Mortality Within 30 Days After Surgery

Arms and interventions

Renal oxygenation-guided perioperative managementExperimental

Bilateral renal regional oxygen saturation will be continuously monitored and displayed to the designated anesthesiologist. A decrease of 10% or more from the corresponding side-specific baseline will trigger assessment of signal validity and a standardized, clinically individualized optimization process addressing volume status, perfusion pressure, cardiac output, heart rate, ventilation and oxygenation, and hemoglobin concentration. Responses after each intervention will be reassessed and recorded.

Usual perioperative management with blinded renal oxygenation monitoringActive comparator

Bilateral renal regional oxygen saturation will be continuously recorded, but values and trends will be hidden from the anesthesia and surgical teams and will not be used to guide care. Participants will receive usual perioperative management according to current clinical practice and local standards.

Devices: INVOS 5100C regional oxygen saturation monitoring system

Other: RrSO2-guided perioperative management, Usual perioperative management

Sites

20 sites in 1 country